Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche

Nature Medicine

Volumn 13, Issue 10, 2007, Pages 1219-1227

  Bi, Yanming ^a   Ehirchiou, Driss ^b   Kilts, Tina M ^a   Inkson, Colette A ^a   Embree, Mildred C ^a   Sonoyama, Wataru ^a   Li, Li ^a   Leet, Arabella I ^c   Seo, Byoung Moo ^a   Zhang, Li ^b   Shi, Songtao ^a,d   Young, Marian F ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIGLYCAN; BONE MORPHOGENETIC PROTEIN; COLLAGEN FIBRIL; FIBROMODULIN;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL POPULATION; CLONOGENESIS; EXTRACELLULAR MATRIX; FIBROCARTILAGE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSSIFICATION; PERIODONTAL LIGAMENT; PRIORITY JOURNAL; STEM CELL; TENDINITIS; TRANSPLANTATION;

ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; CHILD; CHONDROGENESIS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENES, REPORTER; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, TRANSGENIC; OSTEOGENESIS; PROTEOGLYCANS; STEM CELL TRANSPLANTATION; STEM CELLS; TENDONS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34948899331     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1630     Document Type: Article

References (50)

1. Sharma, P. & Maffulli, N. Biology of tendon injury: healing, modeling and remodeling. J. Musculoskelet. Neuronal Interact. 6, 181-190 (2006).
2. Kannus, P. Structure of the tendon connective tissue. Scand. J. Med. Sci. Sports 10, 312-320 (2000).
3. Yoon, J.H. & Halper, J. Tendon proteoglycans: biochemistry and function. J. Musculoskelet. Neuronal Interact. 5, 22-34 (2005).
4. Fenwick, S. et al. Endochondral ossification in Achilles and patella tendinopathy. Rheumatology (Oxford) 41, 474-476 (2002).
5. Salingcarnboriboon, R. et al. Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property. Exp. Cell Res. 287, 289-300 (2003).
6. de Mos, M. et al. Intrinsic differentiation potential of adolescent human tendon tissue: an in vitro cell differentiation study. BMC Musculoskelet. Disord. 8, 16 (2007).
7. Seo, B.M. et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 364, 149-155 (2004).
8. Fuchs, E., Tumbar, T. & Guasch, G. Socializing with the neighbors: stem cells and their niche. Cell 116, 769-778 (2004).
9. Taichman, R.S. & Emerson, S.G. Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J. Exp. Med. 179, 1677-1682 (1994).
10. Zhang, J. et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836-841 (2003).
11. Calvi, L.M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841-846 (2003).
12. Shen, Q. et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304, 1338-1340 (2004).
13. Shi, S. & Gronthos, S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J. Bone Miner. Res. 18, 696-704 (2003).
14. Doherty, M.J. et al. Vascular pericytes express osteogenic potential in vitro and in vivo. J. Bone Miner. Res. 13, 828-838 (1998).
15. Brent, A.E., Schweitzer, R. & Tabin, C.J. A somitic compartment of tendon progenitors. Cell 113, 235-248 (2003).
16. DiCesare, P.E., Morgelin, M., Mann, K. & Paulsson, M. Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding. Eur. J. Biochem. 223, 927-937 (1994).
17. Brandau, O., Meindl, A., Fassler, R. & Aszodi, A. A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin-I. Dev. Dyn. 221, 72-80 (2001).
18. Spangrude, G.J., Heimfeld, S. & Weissman, I.L. Purification and characterization of mouse hematopoietic stem cells. Science 241, 58-62 (1988).
19. Van Vlasselaer, P., Falla, N., Snoeck, H. & Mathieu, E. Characterization and purification of osteogenic cells from murine bone marrow by two-color cell sorting using anti-Sca-1 monoclonal antibody and wheat germ agglutinin. Blood 84, 753-763 (1994).
20. Gussoni, E. et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401, 390-394 (1999).
21. Tamaki, T. et al. Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J. Cell Biol. 157, 571-577 (2002).
22. Welm, B.E. et al. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol. 245, 42-56 (2002).
23. Miura, Y. et al. Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis. Proc. Natl. Acad. Sci. USA 102, 14022-14027 (2005).
24. Simmons, P.J. & Torok-Storb, B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78, 55-62 (1991).
25. Filshie, R.J. et al. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies. Leukemia 12, 414-421 (1998).
26. Kuznetsov, S.A. et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12, 1335-1347 (1997).
27. Bi, Y. et al. Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J. Biol. Chem. 280, 30481-30489 (2005).
28. Krebsbach, P.H. et al. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63, 1059-1069 (1997).
29. Bickenbach, J.R. Identification and behavior of label-retaining cells in oral mucosa and skin. J. Dent. Res. 60, 1611-1620 (1981).
30. Ameye, L. et al. Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J. 16, 673-680 (2002).
31. Cotsarelis, G., Sun, T.T. & Lavker, R.M. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61, 1329-1337 (1990).
32. Morris, R.J. & Potten, C.S. Slowly cycling (label-retaining) epidermal cells behave like clonogenic stem cells in vitro. Cell Prolif. 27, 279-289 (1994).
33. Booth, C. & Potten, C.S. Gut instincts: thoughts on intestinal epithelial stem cells. J. Clin. Invest. 105, 1493-1499 (2000).
34. Scadden, D.T. The stem-cell niche as an entity of action. Nature 441, 1075-1079 (2006).
35. Krause, D.S. Regulation of hematopoietic stem cell fate. Oncogene 21, 3262-3269 (2002).
36. Arai, F. et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118, 149-161 (2004).
37. Moore, K.A. & Lemischka, I.R. Stem cells and their niches. Science 311, 1880-1885 (2006).
38. Blanpain, C. & Fuchs, E. Epidermal stem cells of the skin. Annu. Rev. Cell Dev. Biol. 22, 339-373 (2006).
39. Garcion, E., Halilagic, A., Faissner, A. & Ffrench-Constant, C. Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C. Development 131, 3423-3432 (2004).
40. Nilsson, S.K. et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106, 1232-1239 (2005).
41. Ohta, M., Sakai, T., Saga, Y., Aizawa, S. & Saito, M. Suppression of hematopoietic activity in tenascin-C-deficient mice. Blood 91, 4074-4083 (1998).
42. Stier, S. et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201, 1781-1791 (2005).
43. Schweitzer, R. et al. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development 128, 3855-3866 (2001).
44. Awad, H.A. et al. Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng. 5, 267-277 (1999).
45. Hoffmann, A. et al. Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. J. Clin. Invest. 116, 940-952 (2006).
46. Kuznetsov, S.A., Friedenstein, A.J. & Robey, P.G. Factors required for bone marrow stromal fibroblast colony formation in vitro. Br. J. Haematol. 97, 561-570 (1997).
47. Gimble, J.M. et al. Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. J. Cell. Biochem. 58, 393-402 (1995).
48. Johnstone, B., Hering, T.M., Caplan, A.I., Goldberg, V.M. & Yoo, J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238, 265-272 (1998).
49. Kostenuik, P.J., Halloran, B.P., Morey-Holton, E.R. & Bikle, D.D. Skeletal unloading inhibits the in vitro proliferation and differentiation of rat osteoprogenitor cells. Am. J. Physiol. 273, E1133-E1139 (1997).
50. Lopez-Rovira, T., Chalaux, E., Massague, J., Rosa, J.L. & Ventura, F. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem. 277, 3176-3185 (2002).